Leukemia
Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath-1H for Previously Treated Relapsed or Refractory Patients with Chronic Lymphobastic Leukemia (E2903) [Protocol 61-00]
A Phase 1/2, Single-Arm Study to Assess the Efficacy and Safety of 48-Hour Continuous Intravenous Dosing of ON 01910.Na Administered Once a Week for 3 Weeks of a 4-Week Cycle in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) (04-15) [Protocol 08-091]
